International Patent: COMBINATIONS OF MTOR INHIBITORS, SUCH AS RAPAMYCIN, AND TRKB AGONISTS, SUCH AS N-ACETYL SERATONIN, TO TREAT NEURODEGENERATIVE DISORDERS.

GENEVA, Sept. 7 -- BECKLEY PSYTECH LIMITED filed a patent application (EP2026/055417) for “COMBINATIONS OF MTOR INHIBITORS, SUCH AS RAPAMYCIN, AND TRKB AGONISTS, SUCH AS N-ACETYL SERATONIN, TO TREAT NEURODEGENERATIVE DISORDERS.”. With publication no. WO/2026/180679, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/436

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....